Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRMT5 | O14744 | 2/20 | 0.42 |
| ▸ | WDR77 | Q9BQA1 | 2/20 | 0.42 |
| ▸ | GRM5 | P41594 | 2/20 | 0.40 |
| ▸ | GRM3 | Q14832 | 1/20 | 0.39 |
| ▸ | MCHR1 | Q99705 | 11/20 | 0.39 |
| ▸ | ADAM17 | P78536 | 1/20 | 0.38 |
| ▸ | MAOA | P21397 | 1/20 | 0.37 |
| ▸ | MAOB | P27338 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30716909 | 1.00 | PRMT5 (0.42) | PRMT5WDR77GRM5GRM3MCHR1 | |
| SCHEMBL24667376 | 0.89 | GRM5 (0.40) | PRMT5WDR77GRM5MCHR1ADAM17 | |
| SCHEMBL29987263 | 0.89 | GRM5 (0.40) | PRMT5WDR77GRM5MCHR1ADAM17 | |
| SCHEMBL29986704 | 0.86 | CSNK1A1 (0.39) | PRMT5WDR77GRM5ADAM17 | |
| SCHEMBL24667377 | 0.86 | CSNK1A1 (0.39) | PRMT5WDR77GRM5ADAM17 | |
| SCHEMBL24667425 | 0.85 | HRH3 (0.33) | PRMT5WDR77MCHR1ADAM17 | |
| SCHEMBL24667586 | 0.82 | PRMT5 (0.45) | PRMT5WDR77GRM5GRM3MCHR1 | |
| SCHEMBL29986992 | 0.82 | PRMT5 (0.45) | PRMT5WDR77GRM5GRM3MCHR1 | |
| SCHEMBL24667583 | 0.79 | GRM5 (0.36) | GRM5 | |
| SCHEMBL24667401 | 0.79 | GRM5 (0.36) | GRM5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220339302-A1 | ISOINDOLINONE COMPOUNDS AND IMAGING AGENTS FOR IMAGING HUNTINGTIN PROTEIN | CHDI FOUNDATION, INC. | 2022-10-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220339302-A1 | ISOINDOLINONE COMPOUNDS AND IMAGING AGENTS FOR IMAGING HUNTINGTIN PROTEIN | HTT, HYPK, HSPBP1 | PRMT5 3280/4885WDR77 2074/4885GRM5 1943/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.